Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Clinical Pharmacology

Long‐term outcomes of rituximab therapy in pemphigus

Journal of the European Academy of Dermatology and Venereology | May 08, 2020 Clinical Pharmacology

Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in pediatric patients (≥ 6 to < 12 years of age): Efficacy, safety, pharmacokinetic, and biomarker results from the open‐label CADMUS Jr study

British Journal of Dermatology | May 07, 2020 Clinical Pharmacology

A randomized trial of Lactobacillus rhamnosus IDCC 3201 tyndallizate (RHT3201) for treating atopic dermatitis

Pediatric Allergy and Immunology | May 07, 2020 Clinical Pharmacology

Efficacy and safety of adalimumab 80 mg in the treatment of psoriasis: A bicentric retrospective study

Dermatologic Therapy | May 05, 2020 Clinical Pharmacology

Protective effects of dietary fish‐oil supplementation on skin inflammatory and oxidative stress biomarkers induced by fine particulate air pollution: A pilot randomised, double‐blind, placebo‐controlled trial

British Journal of Dermatology | May 01, 2020 Clinical Pharmacology

Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% BID in patients with acne vulgaris

Journal of the American Academy of Dermatology | Apr 29, 2020 Clinical Pharmacology

Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: Two phase 3 randomized clinical trials

JAMA Dermatology | Apr 25, 2020 Clinical Pharmacology

Long‐term efficacy and safety of apremilast in psoriatic arthritis: focus on skin manifestations and special populations

Dermatologic Therapy | Apr 23, 2020 Clinical Pharmacology

Rifampicin and clarithromycin (extended release) vs rifampicin and streptomycin for limited Buruli ulcer lesions: A randomized, open-label, non-inferiority phase 3 trial

The Lancet | Apr 22, 2020 Clinical Pharmacology

Risk factors for mortality in patients with pulmonary mucormycosis

Mycoses | Apr 22, 2020 Clinical Pharmacology

« Prev 1 … 31 32 33 34 35 … 92 Next »

Long‐term outcomes of rituximab therapy in pemphigus

Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in pediatric patients (≥ 6 to < 12 years of age): Efficacy, safety, pharmacokinetic, and biomarker results from the open‐label CADMUS Jr study

A randomized trial of Lactobacillus rhamnosus IDCC 3201 tyndallizate (RHT3201) for treating atopic dermatitis

Efficacy and safety of adalimumab 80 mg in the treatment of psoriasis: A bicentric retrospective study

Protective effects of dietary fish‐oil supplementation on skin inflammatory and oxidative stress biomarkers induced by fine particulate air pollution: A pilot randomised, double‐blind, placebo‐controlled trial

Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% BID in patients with acne vulgaris

Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: Two phase 3 randomized clinical trials

Long‐term efficacy and safety of apremilast in psoriatic arthritis: focus on skin manifestations and special populations

Rifampicin and clarithromycin (extended release) vs rifampicin and streptomycin for limited Buruli ulcer lesions: A randomized, open-label, non-inferiority phase 3 trial

Risk factors for mortality in patients with pulmonary mucormycosis

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

MD Clip on Pulmonary Hypertension Symptoms and Management with Dr Waseem

New research aims to transform treatments of aggressive blood cancer

Long‐term outcomes of rituximab therapy in pemphigus

Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in pediatric patients (≥ 6 to < 12 years of age): Efficacy, safety, pharmacokinetic, and biomarker results from the open‐label CADMUS Jr study

A randomized trial of Lactobacillus rhamnosus IDCC 3201 tyndallizate (RHT3201) for treating atopic dermatitis

Efficacy and safety of adalimumab 80 mg in the treatment of psoriasis: A bicentric retrospective study

Protective effects of dietary fish‐oil supplementation on skin inflammatory and oxidative stress biomarkers induced by fine particulate air pollution: A pilot randomised, double‐blind, placebo‐controlled trial

Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% BID in patients with acne vulgaris

Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: Two phase 3 randomized clinical trials

Long‐term efficacy and safety of apremilast in psoriatic arthritis: focus on skin manifestations and special populations

Rifampicin and clarithromycin (extended release) vs rifampicin and streptomycin for limited Buruli ulcer lesions: A randomized, open-label, non-inferiority phase 3 trial

Risk factors for mortality in patients with pulmonary mucormycosis

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

MD Clip on Pulmonary Hypertension Symptoms and Management with Dr Waseem

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic